Загрузка...
Does mutated K-RAS oncogene attenuate the effect of Sulindac in colon cancer chemoprevention?
The non-steroidal anti-inflammatory drug (NSAID) Sulindac has been successfully used alone or in combination with other agents to suppress colon tumorigenesis in patients with genetic predisposition, and also showed its efficacy in prevention of sporadic colon adenomas. At the same time, some experi...
Сохранить в:
| Опубликовано в: : | Cancer Prev Res (Phila) |
|---|---|
| Главные авторы: | , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7733710/ https://ncbi.nlm.nih.gov/pubmed/29118162 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-17-0230 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|